Suvretta Capital Management, LLC Kura Oncology, Inc. Transaction History

Suvretta Capital Management, LLC

$3.33 Billion
Q3 2025

A detailed history of Suvretta Capital Management, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 8,116,000 shares of KURA stock, worth $90.9 Million. This represents 2.16% of its overall portfolio holdings.

Number of Shares

8,116,000

Previous 8,116,000 -0.0%

Holding current value

$90.9 Million

Previous $46.8 Million 53.38%

% of portfolio

2.16%

Previous 1.61%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$5.55 - $6.92 $3.76 Million - $4.68 Million	676,741 Added 9.1%	8,116,000 $46.8 Million
Q1 2025 May 15, 2025	BUY	$6.6 - $9.05 $15.6 Million - $21.4 Million	2,362,811 Added 46.54%	7,439,259 $49.1 Million
Q4 2024 Feb 14, 2025	SELL	$8.51 - $19.21 $21.9 Million - $49.5 Million	-2,576,334 Reduced 33.67%	5,076,448 $44.2 Million
Q3 2024 Nov 14, 2024	BUY	$18.57 - $23.23 $10.8 Million - $13.5 Million	583,155 Added 8.25%	7,652,782 $150 Million
Q1 2024 May 15, 2024	BUY	$13.42 - $23.53 $1.66 Million - $2.9 Million	123,397 Added 1.78%	7,069,627 $151 Million

Q4 2023 Feb 14, 2024	SELL	$7.58 - $14.38 $2.95 Million - $5.6 Million	-389,615 Reduced 5.31%	6,946,230 $99.9 Million
Q3 2023 Nov 14, 2023	BUY	$8.44 - $11.86 $2.59 Million - $3.65 Million	307,403 Added 4.37%	7,335,845 $66.9 Million
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $4.38 Million - $6.37 Million	455,107 Added 6.92%	7,028,442 $74.4 Million
Q1 2023 May 15, 2023	BUY	$10.71 - $14.6 $2.1 Million - $2.87 Million	196,520 Added 3.08%	6,573,335 $80.4 Million
Q4 2022 Feb 14, 2023	BUY	$11.23 - $16.9 $26 Million - $39.1 Million	2,313,687 Added 56.94%	6,376,815 $79.1 Million
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $553,997 - $897,189	46,128 Added 1.15%	4,063,128 $55.5 Million
Q2 2022 Aug 15, 2022	BUY	$10.71 - $18.33 $1.33 Million - $2.27 Million	123,981 Added 3.18%	4,017,000 $73.6 Million
Q1 2022 May 16, 2022	BUY	$11.78 - $16.98 $3.78 Million - $5.44 Million	320,600 Added 8.97%	3,893,019 $62.6 Million
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $13.6 Million - $21.8 Million	1,112,217 Added 45.21%	3,572,419 $50 Million
Q3 2021 Nov 15, 2021	BUY	$15.42 - $21.72 $12.4 Million - $17.4 Million	801,496 Added 48.32%	2,460,202 $46.1 Million
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $19.3 Million - $27.7 Million	926,291 Added 126.47%	1,658,706 $34.6 Million
Q1 2021 May 17, 2021	BUY	$24.75 - $39.14 $11.4 Million - $18 Million	460,915 Added 169.77%	732,415 $20.7 Million
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $4.42 Million - $6.35 Million	152,500 Added 128.15%	271,500 $8.87 Million
Q3 2020 Nov 16, 2020	BUY	$16.3 - $30.64 $1.94 Million - $3.65 Million	119,000 New	119,000 $3.65 Million

Others Institutions Holding KURA

# of Institutions

214

Shares Held

81.2M

Call Options Held

900K

Put Options Held

228K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $749M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.

Account

Suvretta Capital Management, LLC Kura Oncology, Inc. Transaction History